
Avinger, Inc.
- Jurisdiction
United States - LEI
549300MRCUER3C2G1659 - ISIN
US0537348775 (AVGR )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€6.19M - Gross margin
20.9% - EBIT
-€14.93M - EBIT margin
-241.0% - Net income
-€15.87M - Net margin
-256.3%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: May 15, 2024 (Q1 2024)